|
22 April 2009
Significant improvement in signs and symptoms in patients suffering from moderate-to-severe dry eye syndrome have been found following the Phase II trial of Cyclokat, the formulation of cyclosporine by French pharmaceutical ophthalmic company Novagali Pharma.
|
15 April 2009
1.25 million neurons view the world through receptive fields, which operate like a multi-layered jigsaw puzzle. Researchers at the Salk Institute for Biological Studies imply that the nervous system operates with higher precision than previously appreciated, and that apparent irregularities in individual cells may actually be coordinated and more finely tuned.
|
15 April 2009
The Schepens Eye Research Institute has found that retinal dysfunction may be caused by blocking the growth factor TGF-beta. The research may have an important impact on the prevention and treatment of diabetic retinopathy and macular degeneration.
|
15 April 2009
"When treating patients with DME, ophthalmologists should consider the role of the glitazone class of drugs," warn the authors of a study published in the April issue of the American Journal of Ophthalmology.
|
15 April 2009
The first ophthalmic surgery in Europe using the CE mark approved I-SIPxAE Adherent Ocular Bandage was conducted in the UK by Dr Daniel Calladine and Mr Richard Packard.
|
15 April 2009
The side effects of an experimental 'gene-silencing' treatment that is currently being investigated for a variety of diseases could be useful in corneal transplantation, where growth of new blood and lymph vessels is believed to be a major cause of graft failure.
|
08 April 2009
In what is believed to be the first comprehensive eye disease study among urban pre-schoolers, investigators writing in the April issue of the journal Ophthalmology report that while vision problems are rare, they are more common than once thought.
|
08 April 2009
Researchers at the Moran Eye Centre are using transmission electron microscopes (TEMs) to develop TEM-compatible molecular probes with software that will tag cells with a molecular signature, creating 'colour' TEM imaging.
|
08 April 2009
One of the world's leading eye research centres, the UCL Institute of Ophthalmology, has been awarded three PhD studentships worth £280,000 tenable from October 2009.
|
|
